Corindus Vascular Robotics Inc (CVRS) Short Interest Up 6.4% in April

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 14,433,050 shares, a growth of 6.4% from the March 29th total of 13,569,380 shares. Based on an average daily volume of 1,229,430 shares, the days-to-cover ratio is currently 11.7 days. Approximately 12.2% of the company’s stock are short sold.

In other news, major shareholder Hudson Executive Capital Lp purchased 2,899,391 shares of the stock in a transaction on Tuesday, March 12th. The stock was bought at an average price of $1.38 per share, with a total value of $4,001,159.58. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Louis A. Cannon purchased 573,798 shares of the stock in a transaction on Tuesday, March 12th. The shares were purchased at an average cost of $1.38 per share, with a total value of $791,841.24. The disclosure for this purchase can be found here. Insiders bought a total of 3,483,189 shares of company stock valued at $4,811,001 in the last three months.

Institutional investors and hedge funds have recently modified their holdings of the business. Canton Hathaway LLC purchased a new position in shares of Corindus Vascular Robotics during the 1st quarter valued at about $63,000. Jane Street Group LLC purchased a new position in shares of Corindus Vascular Robotics during the 4th quarter valued at about $36,000. HRT Financial LLC purchased a new position in shares of Corindus Vascular Robotics during the 4th quarter valued at about $44,000. Virtu Financial LLC purchased a new position in shares of Corindus Vascular Robotics during the 4th quarter valued at about $64,000. Finally, Citadel Advisors LLC raised its stake in shares of Corindus Vascular Robotics by 205.4% during the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock valued at $164,000 after buying an additional 77,829 shares during the last quarter.

Shares of CVRS opened at $2.02 on Friday. Corindus Vascular Robotics has a one year low of $0.70 and a one year high of $2.54.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its quarterly earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.04). The firm had revenue of $4.67 million for the quarter, compared to analyst estimates of $5.60 million.

TRADEMARK VIOLATION WARNING: This news story was published by Finance Daily and is owned by of Finance Daily. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.fidaily.com/2019/04/26/corindus-vascular-robotics-inc-cvrs-short-interest-up-6-4-in-april.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Featured Story: How Does the Quiet Period Work?

Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.